We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Bayer Aktiengesellschaft (PK) | USOTC:BAYRY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 7.36 | 7.40 | 8.10 | 0.00 | 12:40:19 |
From May 2019 to May 2024
European pharma stocks slump as the market drops on reinvigorated trade tensions between China and the U.S. and as a broad sell-off reverberates through bourses. Once insulated from broader market downswings--for example, in the market reaction to a troubled Brexit deal between the U.K. and the EU, European pharma shares bucked the downward trend on account of their global nature--the Stoxx 600's health care sector is now down 1.5%. All major European pharma players drop. Novartis, Roche, Astra, GSK, and Sanofi all shed between 1% and 2%. Bayer is down 2.8%. (donatopaolo.mancini@dowjones.com; @donatopmancini)
(END) Dow Jones Newswires
December 06, 2018 05:10 ET (10:10 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year Bayer Aktiengesellschaft (PK) Chart |
1 Month Bayer Aktiengesellschaft (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
